Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy.

Jønch AE, Danielsen ER, Thomsen C, Meden P, Svenstrup K, Nielsen JE.

BMC Neurol. 2012 Sep 26;12:108. doi: 10.1186/1471-2377-12-108.

2.

General aspects and neuropathology of X-linked adrenoleukodystrophy.

Ferrer I, Aubourg P, Pujol A.

Brain Pathol. 2010 Jul;20(4):817-30. doi: 10.1111/j.1750-3639.2010.00390.x. Review.

PMID:
20626743
3.

Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.

Fourcade S, López-Erauskin J, Galino J, Duval C, Naudi A, Jove M, Kemp S, Villarroya F, Ferrer I, Pamplona R, Portero-Otin M, Pujol A.

Hum Mol Genet. 2008 Jun 15;17(12):1762-73. doi: 10.1093/hmg/ddn085. Epub 2008 Mar 14.

PMID:
18344354
4.

Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy.

Marino S, De Luca M, Dotti MT, Stromillo ML, Formichi P, Galluzzi P, Mondelli M, Bramanti P, Federico A, De Stefano N.

Neurology. 2007 Sep 18;69(12):1261-9.

PMID:
17875914
5.

Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.

Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV.

Neurology. 2005 Jan 25;64(2):304-10.

PMID:
15668429
6.

Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy.

van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV.

Ann Neurol. 2001 Feb;49(2):186-94.

PMID:
11220738
7.

Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study.

van Geel BM, Koelman JH, Barth PG, Ongerboer de Visser BW.

Neurology. 1996 Jan;46(1):112-8.

PMID:
8559356
8.

Failure of repeated cyclophosphamide pulse therapy in childhood cerebral X-linked adrenoleukodystrophy.

Horvath GA, Eichler F, Poskitt K, Stockler-Ipsiroglu S.

Neuropediatrics. 2012 Feb;43(1):48-52. doi: 10.1055/s-0032-1307455. Epub 2012 Mar 19.

PMID:
22430161
9.

Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy.

Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Lemaitre A, Boureau F, Mayer M, Kalifa G.

Neurology. 1992 Jan;42(1):85-91.

PMID:
1734328
10.

Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.

Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S.

Arthritis Rheum. 2002 Feb;46(2):467-74.

PMID:
11840450
11.

Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients.

Pai GS, Khan M, Barbosa E, Key LL, Craver JR, Curé JK, Betros R, Singh I.

Mol Genet Metab. 2000 Apr;69(4):312-22.

PMID:
10870849
12.

[Backache as the initial symptom of adrenomyeloneuropathy].

Benito-León J, Zamorano T, Martín-Peña G, Tapia MA, Alvarez-Linera J.

Rev Neurol. 2000 Dec 16-31;31(12):1167-70. Spanish.

PMID:
11205553
13.

Therapy of X-linked adrenoleukodystrophy.

Semmler A, Köhler W, Jung HH, Weller M, Linnebank M.

Expert Rev Neurother. 2008 Sep;8(9):1367-79. doi: 10.1586/14737175.8.9.1367. Review.

14.

MR imaging of the spinal cord in 23 subjects with ALD-AMN complex.

Snyder RD, King JN, Keck GM, Orrison WW.

AJNR Am J Neuroradiol. 1991 Nov-Dec;12(6):1095-8.

PMID:
1763733
16.
17.

[X-linked adrenoleukodystrophy--2 case reports].

Dumić M, Ille J, Plavsić V, Filipović-Grcić B, Vrljicak K, Barisić N, Roscher A.

Lijec Vjesn. 1998 Jan-Feb;120(1-2):19-23. Croatian.

PMID:
9650481
18.

Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).

Boruchov DM, Gururangan S, Driscoll MC, Bussel JB.

Blood. 2007 Nov 15;110(10):3526-31. Epub 2007 Aug 13.

19.

Auditory brainstem response findings and peripheral auditory sensitivity in adrenoleukodystrophy.

Pillion JP, Kharkar S, Mahmood A, Moser H, Shimizu H.

J Neurol Sci. 2006 Sep 25;247(2):130-7. Epub 2006 Jun 5.

PMID:
16737712
20.

Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy.

Asano J, Suzuki Y, Yajima S, Inoue K, Shimozawa N, Kondo N, Murase M, Orii T.

Brain Dev. 1994 Nov-Dec;16(6):454-8.

PMID:
7694994

Supplemental Content

Support Center